Dextran 75: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Dextran 75. Educational only — not medical advice.
Labeled uses
Technetium Tc99m Dextran by intravenous administration is indicated as a cardiac blood pool imaging agent and as an adjunct in the diagnosis of pericardial effusion, ventricular aneurysm, or GI Bleed
Source: FDA labeling via NIH DailyMed (set a71129ae…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.